Impact of methicillin resistance on mortality in Staphylococcus aureus endocarditis: a systematic review and meta-analysis
Open Access
- 29 June 2026
- journal article
- review article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Background Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a leading cause of endocarditis with poor outcomes. The magnitude and consistency of its mortality risk compared with methicillin-susceptible S. aureus (MSSA) remain uncertain. Methods Data were extracted from PubMed, Embase, Scopus, and Cochrane Library from database inception to 30 November 2025, without language restrictions. A random-effects model (Restricted Maximum-Likelihood) was used to calculate pooled risk ratios (RRs). Heterogeneity was explored by stratified and meta-regression analyses. Publication bias was assessed using funnel plot symmetry and Egger’s regression. Results Twenty-four studies, comprising 3291 patients (1,011 with MRSA and 2280 with MSSA), met the inclusion criteria. Pooled short-term mortality was significantly higher in MRSA endocarditis (30.9% vs 25.6%; RR 1.48, 95% CI 1.21-1.80; I² = 34%). Across stratified analyses by study design, setting, region, and study era, mortality remained consistently higher in MRSA endocarditis. No significant differences were found for heart failure (RR 1.08, 95% CI 0.90-1.30), embolic events (RR 0.82, 95% CI 0.51-1.33), stroke (RR 0.88, 95% CI 0.78-1.00), or surgery performed (RR 0.97, 95% CI 0.56-1.68) in MRSA and MSSA groups. No publication bias was revealed by Funnel-plot inspection and Egger’s test (p = 0.082). Meta-regression showed no effect modification by age, hospital-acquired infection, prosthetic valve, or right-sided endocarditis. Conclusions MRSA endocarditis carries a significantly higher short-term mortality than MSSA, consistent across study designs and study-level characteristics. The major complications were comparable between the two groups.Keywords
This publication has 45 references indexed in Scilit:
- Epidemiological Profile and Mortality of Infective Endocarditis Over the Past Decade: A Systematic Review and Meta-Analysis of 133 StudiesThe American Journal of Cardiology, 2025
- Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureusEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- The Golden Grapes of Wrath – Staphylococcus aureus Bacteremia: A Clinical ReviewThe American Journal of Medicine, 2022
- Comparison of mortality, stroke, and relapse for methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infective endocarditis: a retrospective cohort studyDiagnostic Microbiology and Infectious Disease, 2021
- Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective EndocarditisJAMA Network Open, 2020
- Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Persistent Staphylococcus aureus BacteremiaAn Analysis of Risk Factors and OutcomesArchives of internal medicine (1960), 2007
- Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective EndocarditisThe Annals of Thoracic Surgery, 2007
- Staphylococcus aureus EndocarditisJAMA, 2005
- Clinical Features of Staphylococcus aureus EndocarditisArchives of internal medicine (1960), 1999